Success Metrics

Active Trials
3(50%)

Phase Distribution

Ph phase_2
2
33%
Ph phase_3
1
17%
Ph phase_1
3
50%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Other(1)

Detailed Status

Active, not recruiting3
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
Phase 31 (16.7%)

Trials by Status

unknown117%
not_yet_recruiting233%
active_not_recruiting350%

Recent Activity

3 active trials
Showing 5 of 6
not_yet_recruitingphase_3

NTI164 in Autism Spectrum Disorder

NCT07257939
not_yet_recruitingphase_2

Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

NCT07257978
active_not_recruitingphase_1

NTI164 Human PK Study

NCT06713447
active_not_recruitingphase_1

Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)

NCT06621888
active_not_recruitingphase_1

Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)

NCT06621043
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07257939Phase 3

NTI164 in Autism Spectrum Disorder

Not Yet Recruiting
NCT07257978Phase 2

Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome

Not Yet Recruiting
NCT06713447Phase 1

NTI164 Human PK Study

Active Not Recruiting
NCT06621888Phase 1

Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Active Not Recruiting
NCT06621043Phase 1

Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)

Active Not Recruiting
NCT05626959Phase 2

Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6